Dashboard
Manage Tickers

LUNG


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

a-glimpse-into-the-expert-outlook-on-pulmonx-through-6-analysts
A Glimpse Into The Expert Outlook On Pulmo...
09/08/2025 14:00:31

d-boral-capital-maintains-buy-on-pulmonx-maintains-16-price-target
D. Boral Capital Maintains Buy on Pulmonx,...
09/08/2025 11:17:56

D. Boral Capital analyst Jason Kolbert maintains Pulmonx (NASDAQ:LUNG) with a Buy and maintains $16 price target.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 21:06:39

jaeger-and-pulmonx-announce-strategic-partnership-to-integrate-data-qualification-capabilities-into-sentrysuite
Jaeger And Pulmonx Announce Strategic Part...
08/27/2025 13:13:41

Jaeger™ Medical, a global leader in respiratory diagnostic products, is pleased to announce a strategic partnership with Pulmon...

wells-fargo-maintains-equal-weight-on-pulmonx-lowers-price-target-to-3
Wells Fargo Maintains Equal-Weight on Pulm...
08/01/2025 14:10:41

Wells Fargo analyst Larry Biegelsen maintains Pulmonx (NASDAQ:LUNG) with a Equal-Weight and lowers the price target from $6 ...

lake-street-maintains-buy-on-pulmonx-lowers-price-target-to-8
Lake Street Maintains Buy on Pulmonx, Lowe...
07/31/2025 22:54:12

Lake Street analyst Frank Takkinen maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $12 to $8.

analyst-expectations-for-pulmonxs-future
Analyst Expectations For Pulmonx's Future
07/31/2025 19:00:59

crude-oil-falls-1-meta-earnings-top-views
Crude Oil Falls 1%; Meta Earnings Top Views
07/31/2025 17:25:08

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/31/2025 17:08:07

stifel-maintains-buy-on-pulmonx-lowers-price-target-to-5
Stifel Maintains Buy on Pulmonx, Lowers Pr...
07/31/2025 16:06:40

Stifel analyst Rick Wise maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $16 to $5.

nasdaq-surges-over-1-microsoft-posts-upbeat-earnings
Nasdaq Surges Over 1%; Microsoft Posts Upb...
07/31/2025 14:12:21

piper-sandler-downgrades-pulmonx-to-neutral-lowers-price-target-to-25
Piper Sandler Downgrades Pulmonx to Neutra...
07/31/2025 12:10:09

Piper Sandler analyst Jason Bednar downgrades Pulmonx (NASDAQ:LUNG) from Overweight to Neutral and lowers the price target f...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/31/2025 12:08:18

d-boral-capital-maintains-buy-on-pulmonx-lowers-price-target-to-16
D. Boral Capital Maintains Buy on Pulmonx,...
07/31/2025 11:09:39

D. Boral Capital analyst Jason Kolbert maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $17 to $16.

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/30/2025 21:06:56

pulmonx-lowers-fy2025-sales-guidance-from-96000m-98000m-to-90000m-92000m-vs-96951m-est
Pulmonx Lowers FY2025 Sales Guidance from ...
07/30/2025 20:13:21

Pulmonx (NASDAQ:LUNG) lowers FY2025 sales outlook from $96.000 million-$98.000 million to $90.000 million-$92.000 million vs $9...

pulmonx-q2-eps-038-beats-040-estimate-sales-23859m-beat-23462m-estimate
Pulmonx Q2 EPS $(0.38) Beats $(0.40) Estim...
07/30/2025 20:08:24

Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.40) by 5 ...

Core News & Articles
Earnings Scheduled For July 30, 2025
07/30/2025 08:32:48

demystifying-pulmonx-insights-from-6-analyst-reviews
Demystifying Pulmonx: Insights From 6 Anal...
05/22/2025 19:00:52

citigroup-maintains-neutral-on-pulmonx-lowers-price-target-to-415
Citigroup Maintains Neutral on Pulmonx, Lo...
05/22/2025 17:37:13

Citigroup analyst Joanne Wuensch maintains Pulmonx (NASDAQ:LUNG) with a Neutral and lowers the price target from $6.5 to $4.15.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION